These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 24295642)

  • 41. The enterohepatic circulation of bile acids in man.
    Hofmann AF
    Adv Intern Med; 1976; 21():501-34. PubMed ID: 766594
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Kinetics of the normal folate enterohepatic cycle.
    Steinberg SE; Campbell CL; Hillman RS
    J Clin Invest; 1979 Jul; 64(1):83-8. PubMed ID: 447863
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Disposition and enterohepatic circulation of diclofenac in dogs.
    Tsuchiya T; Terakawa M; Ishibashi K; Noguchi H; Kato R
    Arzneimittelforschung; 1980; 30(10):1650-3. PubMed ID: 7192104
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Asymptotics and bioavailability in multicompartment pharmacokinetic models with enterohepatic circulation.
    Horkovics-Kovats S; Zlatos P
    Math Biosci; 2003 Jul; 184(1):69-99. PubMed ID: 12788234
    [TBL] [Abstract][Full Text] [Related]  

  • 45. On the population pharmacokinetics and the enterohepatic recirculation of total ezetimibe.
    Soulele K; Karalis V
    Xenobiotica; 2019 Apr; 49(4):446-456. PubMed ID: 29629619
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 1st communication: absorption, concentrations in plasma, metabolism, and excretion after single administration to rats and dogs.
    Boberg M; Ahr HJ; Beckermann B; Bühner K; Siefert HM; Steinke W; Wünsche C; Hirayama M
    Arzneimittelforschung; 1997 Aug; 47(8):928-38. PubMed ID: 9296279
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Gallbladder-Based Enterohepatic Circulation Model for Pharmacokinetic Studies.
    Okour M; Brundage RC
    Eur J Drug Metab Pharmacokinet; 2019 Aug; 44(4):493-504. PubMed ID: 30488336
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A time-lag model for pharmacokinetics of drugs subject to enterohepatic circulation.
    Steimer JL; Plusquellec Y; Guillaume A; Boisvieux JF
    J Pharm Sci; 1982 Mar; 71(3):297-302. PubMed ID: 7069584
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Importance of Considering Fed-State Gastrointestinal Physiology in Predicting the Reabsorption of Enterohepatic Circulation of Drugs.
    Nakamura K; Kambayashi A; Onoue S
    Pharm Res; 2024 Apr; 41(4):673-685. PubMed ID: 38472609
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A variable reabsorption time-delay model for pharmacokinetics of drugs.
    Labat C; Mansour K; Malmary MF; Terrissol M; Oustrin J
    Eur J Drug Metab Pharmacokinet; 1987; 12(2):129-33. PubMed ID: 3691578
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Necessary modification of formulae estimating the reabsorption rate for drugs subject to enterohepatic recirculation.
    Kurita M
    J Pharmacokinet Biopharm; 1991 Aug; 19(4):469-72. PubMed ID: 1920090
    [No Abstract]   [Full Text] [Related]  

  • 52. Pharmacokinetic Simulation and Area under the Curve Estimation of Drugs Subject to Enterohepatic Circulation.
    Alpízar M; de Jesús Reséndiz J; García Martínez E; Dwivedi S; Trejo MA
    Pharmaceutics; 2024 Aug; 16(8):. PubMed ID: 39204389
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multiple peaking phenomena in pharmacokinetic disposition.
    Davies NM; Takemoto JK; Brocks DR; Yáñez JA
    Clin Pharmacokinet; 2010 Jun; 49(6):351-77. PubMed ID: 20481648
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Noncompartmental area under the curve determinations for drugs that cycle in the bile.
    Colburn WA; Lucek RW
    Biopharm Drug Dispos; 1988; 9(5):465-75. PubMed ID: 3224163
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Disposition analysis by fast inverse Laplace transform (FILT)].
    Yamaoka K
    Yakugaku Zasshi; 1992 Aug; 112(8):503-15. PubMed ID: 1432601
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Enterohepatic circulation of drugs.
    Dobrinska MR
    J Clin Pharmacol; 1989 Jul; 29(7):577-80. PubMed ID: 2760253
    [No Abstract]   [Full Text] [Related]  

  • 57. The influence of nutrition on the systemic availability of drugs. Part II: Drug metabolism and renal excretion.
    Walter-Sack I
    Klin Wochenschr; 1987 Nov; 65(21):1062-72. PubMed ID: 3323646
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Kinetics of indomethacin absorption, elimination, and enterohepatic circulation in man.
    Kwan KC; Breault GO; Umbenhauer ER; McMahon FG; Duggan DE
    J Pharmacokinet Biopharm; 1976 Jun; 4(3):255-80. PubMed ID: 978392
    [No Abstract]   [Full Text] [Related]  

  • 59. A new method to estimate parameters of pharmacokinetics with enterohepatic circulation.
    Abi Khalil F; Hanocq M; Dubois J
    Eur J Drug Metab Pharmacokinet; 1993; 18(2):131-9. PubMed ID: 8243495
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lead PK commentary: predicting human pharmacokinetics.
    Rowland M; Benet LZ
    J Pharm Sci; 2011 Oct; 100(10):4047-9. PubMed ID: 21630278
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.